Skip to main content
Premium Trial:

Request an Annual Quote

Transgenomic Pre-announces Lowered Q2 Revenues

NEW YORK, July 15 - Transgenomic today announced that its second quarter revenues would fall short year-over-year.

 

The Omaha, Neb., company estimated its total sales to be $8.4 million for the second quarter, compared to $9.4 million for the second quarter of 2002.

 

Transgenomic also said that it expected its operating expenses to be $7.1 million for the quarter, including restructuring charges of $475,000, compared to $8.9 million in the second quarter of 2002.

 

The company attributed its flagging sales to weakness in its nucleic acid business unit, which manufactures synthetic oligonucleotides and other components of nucleic acids for genetic diagnostics and therapeutics purposes. Transgenomic said sales were over 15 percent higher than in the second quarter of 2002 in its Biosystems unit, which sells its Wave instrument for detecting mutations in nucleic acids.

 

"We continue to suffer from a lack of revenue visibility in our nucleic acid business, as some of our pharmaceutical and biopharmaceutical customers deal with details of timing and logistics," Collin D'Silva, CEO, said in a statement. " We are confident that the planned launch of several product line extensions will help to solidify biosystems business unit revenues, and we remain optimistic about improvement in our nucleic acids business."

 

Transgenomic plans to announce second quarter results on Tuesday, August 5.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.